Goldman Likes These 3 Stocks
Stocks are lower Wednesday as oil climbs over $50.
New home sales for April rose +0.2% to 1.316 million units…record highs but
below estimates. April durable goods orders rose +1.9%; ex transportation, -0.2%
March was revised to -1.6%. The homebuilders are weak on the March home sales
revision.
Crude oil inventories fell 1.6 million barrels–traders were expecting a
build. Gas inventories rose +0.6 million barrels.
Goldman reiterated its outperform rating on Google
(
GOOG |
Quote |
Chart |
News |
PowerRating),
Yahoo
(
YHOO |
Quote |
Chart |
News |
PowerRating) and Ebay
(
EBAY |
Quote |
Chart |
News |
PowerRating). Separately, JP Morgan raised
estimates on Google.
Visteon
(
VC |
Quote |
Chart |
News |
PowerRating) is restructuring as part of a deal with Ford. The
stock is higher pre-open.
Autozone
(
AZO |
Quote |
Chart |
News |
PowerRating) beat by 0.06; sales, however, were weaker than
expected.
Strong sectors are:Â Oil Services
(
$OSX.X |
Quote |
Chart |
News |
PowerRating) +1.91%Â Â Â
Oil
(
$XOI.X |
Quote |
Chart |
News |
PowerRating) +0.85%Â Natural Gas
(
$XNG.X |
Quote |
Chart |
News |
PowerRating)
+0.30%Â Â Â Â Â
Weak sectors are:Â Â Chemicals
(
$CEX.X |
Quote |
Chart |
News |
PowerRating) -1.54% Â Semis
(
$SOX.X |
Quote |
Chart |
News |
PowerRating)
-1.46%Â Â Biotech Â
(
$BTK.X |
Quote |
Chart |
News |
PowerRating)
-1.17%
Dow | -63.18 | 10,440.50 |
Nasdaq | -16.96 | 2044.66 |
S&P 500 | -6.58 | 1187.49 |
The dollar is -0.05 at
86.32
Crude Oil is +1.18 at
50.85
Gold is -0.10 at 417.90
ce=”Arial” size=”2″ face=”Arial”>Volume is 710 million on the NYSE and
665 million on the Nasdaq.
Market breadth is negative.
NYSE | Issues | |
Advancing | 897 | Up Vol 206 |
Declining | 2176 | Down Vol 432 |
2.42 | 2.09 | |
Nasdaq |
||
Advancing | 841 | Up Vol 168 |
Declining | 1974 | Down Vol 453 |
2.34 | 2.69 |
Stocks in the News
Computer Sciences
(
CSC |
Quote |
Chart |
News |
PowerRating) beat by 0.02 and raised 2006 guidance.
Echostar
(
DISH |
Quote |
Chart |
News |
PowerRating) was cut to ‘neutral’ at Bank of America.
UBS cut Genzyme
(
GENZ |
Quote |
Chart |
News |
PowerRating) to ‘neutral.’
Calpine
(
CPN |
Quote |
Chart |
News |
PowerRating) is restructuring; the stock is higher pre-open.
Encysive
(
ENCY |
Quote |
Chart |
News |
PowerRating) received an FDA application for PAH.
Medtronic
(
MDT |
Quote |
Chart |
News |
PowerRating) was in-line but light on revenues.Â
Boston Scientific
(
BSX |
Quote |
Chart |
News |
PowerRating) lowered guidance, citing acquisitions and
updated expectations for the Taxus stent.
Network Appliance
(
NTAP |
Quote |
Chart |
News |
PowerRating) was in-line and announced a $300 share
repurchase program.
Brice Wightman
Â
Â
Â
Â